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Abstract
Purpose of review Non-obstructive coronary artery disease (NOCAD) on coronary
angiography is a common finding in patients with stable angina. Angina in NOCAD
patients is thought to be caused by endothelial dysfunction of the epicardial
coronary arteries and/or the microvasculature. Treatment is empiric, and 30% of
patients remain symptomatic in spite of therapy. It is well known that physical
exercise can improve endothelial function. The goal of this review was to assess
the current literature on effects of physical exercise in NOCAD patients with
angina. Therefore, a literature search was conducted to March 13, 2018 using
the following search terms: syndrome X, microvascular angina, non-obstructive
coronary artery disease and exercise training, cardiac rehabilitation, endothelial
function. All original publications were included which examined the effect of a
cardiac rehabilitation (CR) program or exercise training (ET) on patients with
angina and NOCAD.
Recent findings Eight studies, of which four were randomized controlled studies, exam-
ined 218 participants, 162 in an intervention and 56 in control groups. Most patients were
women (97.7%). Exercise programs varied from 8 weeks to 4 months at moderate intensity
and some included relaxation therapy. The studies examined the effect of CR on exercise
capacity, quality of life (QoL), and perfusion defects. CR increased exercise capacity,
oxygen uptake, symptom severity, and QoL. Myocardial perfusion improved.
Summary CR appears to be beneficial in symptomatic patients with NOCAD, improving exercise
capacity and QoL and reducing severity of symptoms and myocardial perfusion defects. Data is
limited to a small number of predominantly female patients. Further larger trials are warranted
to determine the optimal rehabilitation protocols and define its long-term benefits.
Introduction
Non-obstructive coronary artery disease (NOCAD) is
often found on coronary angiograms performed in pa-
tients with stable angina, with up to 60% of women
having NOCAD [1••]. Angina in the context of NOCAD
appears to be caused by endothelial dysfunction at the
epicardial and/or microvascular level [2•]. Albeit a
heterogonous population, the consensus is that inap-
propriate coronary vasodilator capacity is the common
denominator [2•]. Patients previously diagnosed with
“cardiac syndrome X” (CSX) also belong to this entity
and are now classified as microvascular angina [3].
Numerous studies indicate an increased risk of car-
diovascular events in these patients and high costs due
to frequent rehospitalization, repeat diagnostic proce-
dures, and medical therapy [1••, 4, 5]. Approximately
one third of patients remain symptomatic in spite of
therapeutic interventions, which are often empirical [5,
6•]. NOCAD angina is associated with depression and
decreased quality of life (QoL) [7]. The duration and
intensity of symptoms are independent predictors of
reduced QoL in women with NOCAD [8].
It iswell known that exercise improves endothelial func-
tion in patients with coronary artery disease (CAD) [9] and
heart failure [10]. Furthermore, exercise training (ET) is a
fundamental part of cardiac rehabilitation (CR) which has
been repeatedly shown to reduce cardiovascular mortality
and rehospitalization rates and improvepsychologicalwell-
being and risk factor control in patientswithCAD [11].
The goal of the systematic review was to appraise
available literature on CR in patients with NOCAD/
microvascular angina and to assess whether there is evi-
dence suggestive of a potential benefit in these patients
with respect to endothelial function, cardiovascular out-
comes, symptom control, QoL, and exercise capacity.
Methods
Studies were identified by conducting systematic searches of PubMed,
EMBASE, and the Cochrane Library up until March 13, 2018. Searches
included a mix of MeSH and free text terms related to syndrome X,
microvascular angina, non-obstructive coronary artery disease, exercise
training, cardiac rehabilitation, and endothelial function. Additionally,
systematic reviews and reference lists of papers were hand searched for
additional studies. All clinical trials with ET/CR in symptomatic patients
with NOCAD were included. The selection was not limited to random-
ized controlled trials because of the paucity of data in this field. Articles
written in languages other than English were excluded.
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Results
Eight original articles included 218 patients, of which 162 underwent an
intervention, and 56 served as controls. Themajority of patients in these studies
were women (97.7%). Inclusion criteria were ongoing exertional chest pain
(CP) without significant CAD on CT scan or coronary angiography, and the
majority of studies required a positive exercise stress test or perfusion scan. The
studies were conducted in five different countries (UK, Poland, Sweden, Brazil,
Iran). Four of the studies were randomized, controlled clinical studies [12–15].
The first study on physical training in patients with CSX was published by
Eriksson et al. in 2000 [13]. The authors randomized women into three groups
which consisted of 8-week body-awareness (BA) program followed by 8 weeks
of ET (total of 16 weeks), 8 weeks of ET alone, or a no-intervention control
group [13]. Exercise training entailed cycle ergometer training three times a
week for 30 min at 50% of peak work rate, which was determined at the
beginning of the study. Endpoints were exercise capacity, urinary excretion of
catecholamines and cortisol as an indicator for “negative stress,” adenosine
sensitivity test as a measure for pain sensitivity, and assessment of flow-
mediated dilation (FMD) as an indicator of endothelial function. The authors
were able to show that ET but not BA improved the exercise capacity by 36%
and oxygen uptake by 26%. Time to pain onset changed significantly after ET,
but not after sole BA training. Pain sensitivity was not affected by BA or ET.
Cortisol levels decreased after BA, whereas catecholamine levels remained
unchanged. There was a trend towards an improved endothelial function in
the ET cohort [13].
The same study group examined 21 women in 2002 [12]. They randomized
women into three groups (A, ET; B, Jacobson relaxation therapy, autogenous
training; C, control group). ET consisted of the same protocol as in the prior
study [13]. QoL and coping capacity were examined by three different ques-
tionnaires (SOC, SCI-93, SIP) [12]. Health-related QoL improved in both the
ET and the relaxation therapy groups, which was not associated with improved
coping strategies [12].
In 2008, Asbury et al. published data on 64womenwith diagnostic criteria for
CSX, which were randomized into two groups [15]. One group underwent a
standard 8-week group-based phase III CR program, which included an 80-min
hospital-based circuit training once a week with the aim to exercise at 60–75% of
their age-predicted heart rate reserve [15]. This was complemented by a home
exercise session once a week. The other half had an 8-week symptom-monitoring
program only. The patients’ physical capacity was assessed by progressive shuttle
walk (PSW) test. Each patient was asked to complete a symptom-monitoring
diary daily and to fill out five different questionnaires to assess their psychological
health (Health Anxiety Questionnaire, Hospital Anxiety and Depression Scale,
SF-36, Cardiac Anxiety Questionnaire, Demographic Information Scale) at the
beginning and at the end of the study. Compared to controls, women in the ET
group showed significantly reduced symptom severity and psychological mor-
bidity and were able to walk a longer distance in the PSW test [15].
Feizi et al. examined 40 women with CSX in Iran in 2012 [14]. Patients were
randomized into four groups ((1) control, (2) CR only, (3) progressive muscle
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relaxation (PMR) only, (4) CR + PMR). The PMR group was instructed to
perform Jacobson’s method for 15 min per day at home. The CR group
performed a home-based phase III program that consisted of an initial 25-
min walk, which gradually increased to 40 min at 60–65% of maximum heart
rate, three times per week, for 8 weeks. The fourth group combined PMR and
CR. Outcomes were assessed by the SF-36 questionnaire. In all three interven-
tion groups, QoL improved. However, the combination of CR and PMR led to
the most pronounced improvement of QoL scores [14].
Carvalho et al. published data from Brazil in 2014 [16]. Patients were
included with exertional CP, normal coronary angiography, and presence of
≥ 2 myocardial segments with reversible perfusion defects (RPDs) identified by
SPECTmyocardial perfusion scan. This was the only study which included men
(5/12). Patients underwent a 4-month rehabilitation program that consisted of
three sessions per week of treadmill training at 60–85% of peak VO2. The
program also included global stretching (5 min), resistance exercise (10 min),
and relaxation (5 min). At the end of the program, SPECT was repeated, as well
as application of the SF-36 questionnaire. The authors showed a 14% increase
in oxygen uptake and were able to show a significant reduction in myocardial
ischemia on SPECT (SDS, summed difference score). There was a significant
improvement of the SF-36 scores in all categories but general health status [16].
In a further study, Carvalho et al. compared the same patient population with a
healthy control group in regard to left ventricular ejection fraction (LVEF) at
peak exercise on radionuclide ventriculography [17]. Compared to healthy
controls, the LVEF in patients withMA did not rise significantly at peak exertion
and this did not improve with exercise training over 4 months [17].
The latest studies were published by Szot et al. from Poland who examined
55 women with CSX and RPDs on SPECT [18]. Patients underwent an exercise
program for 3 months with ET scheduled three times a week for 90 min (30-
min warm-up, 30-min bicycle ergometer, 30-min relaxation). The training
intensity was increased from 70 to 100 W after 4 weeks and to 120 W after
another month. The intensity was reduced if 80% of maximum heart rate was
achieved. After 3 months, the Ferrans & Powers Quality of Life Index question-
naire was repeated, as well as SPECT. The authors demonstrated a 20% increase
in exercise capacity, as well as an improved perfusion on SPECT during exercise.
There was a weak correlation between improved SDS and QoL [18]. The same
study group published another paper with the same cohort, showing an in-
crease in exercise capacity, improved systolic and diastolic blood pressure,
reduced body mass index (BMI), and improved SDS [19].
In summary, the duration of the exercise programs varied from 8 weeks
to 4 months, with most of the programs lasting 8 weeks (Table 1). The
majority of interventions were hospital-based. Only Feizi et al. prescribed a
solely home-based program, whereas Asbury et al. used a mix of hospital-
and home-based sessions. Most of the exercise programs performed three
training sessions per week that lasted at least 30 min, only Asbury et al.
prescribed three sessions per week of longer duration (Table 1). The
minimum training time per week was 90 min. The training mostly
consisted of cycle ergometer but also included walking for the home-
based program. Exercise intensity varied between the different studies but
most authors tried to achieve a moderate intensity, guided by percentage
of maximum heart rate [14, 18, 19], heart rate reserve [15], peak VO2 [16],
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or peak work rate [12, 13] (Table 1). Figure 1 summarizes the positive
effects of CR in symptomatic patients with NOCAD. ET improved exercise
capacity in all studies, albeit to a varying extent. In addition, ET improved
QoL and symptom severity in most studies. The combination of relaxation
therapies with ET or relaxation therapy alone appeared to have a positive
impact on QoL parameters in three studies.
Discussion
Review of the current literature on effects of physical exercise in NOCAD
patients with angina yielded a limited number of studies. ET appears to be
beneficial in patients with CSX/microvascular angina who are notoriously
difficult to treat with one third remaining symptomatic in spite of treatment
[5]. Albeit training protocols differed between the study populations, moderate
activity 2–3 times per week (minimum of 90 min/week) appears to improve
physical functioning over 8weeks. This is of importance since impaired physical
functioning is a feature of symptomatic patients withNOCAD [7]. Furthermore,
Jespersen et al. showed that severity of persistent angina is associated with
impaired physical functioning and QoL in NOCAD patients [7]. Asbury et al.
demonstrated that ET reduced the severity of pain episodes, whichmay partially
explain the improved QoL [15]. It remains uncertain whether this is mediated
by an increased myocardial perfusion through improved coronary endothelial
function. None of the studies looked at coronary endothelial function directly.
One study showed a trend towards improvement of peripheral endothelial
function using FMD, despite the fact that the study was underpowered [13].
There is also one case report which supports this hypothesis by showing a
reversal of RPDs together with an improved peripheral endothelial function
[20]. Furthermore, studies in diabetic patients with CAD showed that coronary
endothelial function is improved by ET, whichmight explain the positive effects
observed in the NOCAD population [21].
Although a variety of exercise protocols seem to have a beneficial effect on
symptomatic patients with NOCAD, the optimal training strategy and guidance
Exercise Training
(Cardiac Rehabilitation)
Exercise Capacity
↑ 20-36%
Improves
Quality of Life
↓ BMI
Improves
Symptoms
Peak VO
2
↑ 13-26%
Perfusion defects
SDS ↓ 83%
Chest Pain
with NOCAD
Fig. 1. Beneficial effects of cardiac rehabilitation in patients with NOCAD. BMI, body mass index; SDS, summation difference score;
NOCAD, non-obstructive coronary artery disease, VO2, oxygen uptake.
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remain uncertain. Carvalho et al. used a longer duration of the CR program
(4months) but did not adapt the training intensity over the course of the program
and patients had only a mild increase in VO2 of 13% [16]. The authors were not
able to show an improvement in general health status as assessed by SF-36. This
may be related to the limited training effect. Another possible explanation is that
the SF-36questionnaire is awell-established generic questionnaire,which evaluates
parameters like general health perception, social functioning, and mental health
[22]. Application of a more disease-specific questionnaire such as the Seattle
Angina questionnaire might have yielded different results [23].
As recommended by guidelines, authors chose mostly a moderate training
intensity, although guidance parameters varied between the studies. A meta-
analysis recently showed that high-intensity training improves endothelial
function in patients with cardiovascular disease [24], hereby raising the ques-
tion whether it might be a time-efficient alternative or addition in NOCAD
patients. Furthermore, training strategies like skiing appear to have a beneficial
effect on endothelial health, which might broaden the recommended exercise
spectrum, at least in alpine regions [25].
The reported trials have several limitations. Firstly, they were all small with
low patient numbers in each treatment group, hereby limiting statistical power.
In addition, not all of the studies were randomized. Secondly, the majority of
studies included only women (97.7%). Although cardiac syndrome X is more
common in women, it is well established that it also occurs in men, with up to
30% of men with SA presenting for coronary angiogram, have NOCAD [1••].
Given that the studies were limited to women, we can only speculate whether
ET has the same positive effect in men.
Outcome measures in the reported trials consisted mostly of parameters for
exercise capacity, easily measurable physical values, and QoL assessed by ques-
tionnaires. All outcomes were evaluated in the short term, directly after com-
pletion of the CR program. No data is available on the long-term effects of CR
programs in NOCAD, and whether the beneficial effect is sustained over time.
Furthermore, it would be interesting whether this transfers into hard endpoints
like less frequent hospitalization, lower treatment costs, and possibly an im-
proved outcome. For a long time, symptomatic patients with NOCAD were
assured of the benign nature of their condition. However, recent data points
towards an adverse outcome of these patients in regard to myocardial infarc-
tion, cardiovascular, and all-cause mortality [1••, 26]. Therefore, it would be
intriguing to assess whether CR also leads to an improved cardiovascular
outcome in this patient population.
Future research
Current studies on the effect of ET in symptomatic patients with NOCAD are
promising but larger, randomized studies with inclusion of male patients are
needed to evaluate the benefit of ET on hard endpoints and the long-term effect
of ET. Furthermore, a study protocol should include randomized groups to
determine the optimal training protocol in regard to training intensity, dura-
tion, and inclusion of relaxation techniques. Furthermore, it would be of
interest to include vascular function studies to gain further insight into the
pathophysiological mechanisms.
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Conclusion
Available evidence suggest that exercise training in women with angina and
NOCAD has a beneficial effect on exercise capacity, severity of symptoms, and
quality of life and appears to improve myocardial perfusion defects. Further,
larger trials with inclusion ofmen are warranted in this challenging population,
which is commonly subjected to numerous medical and invasive therapies of
uncertain efficacy.
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